BioSpace News Archive

Deals

Traditions Health Expands Presence in Greater Austin Area; Acquires Guiding Hospice

Traditions Health, LLC, a hospice and home health provider in Texas, California and Arizona, announced that it has acquired Guiding Hospice.

December 23, 2019
·
1 min read
Drug Development

Sensorion Announces Positive Data Safety Monitoring Board Review of Phase 2 Trial for SENS-401 in Sudden Sensorineural Hearing Loss

Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) today announces that an independent Data Safety Monitoring Board (DSMB) has undertaken a review of the safety data for the patients who were included into the phase 2 clinical trial for SENS-401 in the treatment of Sudden Sensorineural Hearing Loss (SSNHL).

December 23, 2019
·
4 min read
Policy

Update - Advisory - Health Canada warns that products sold by Dutta Health Centre-Ayurvedic Clinic in Surrey, B.C., may pose health risks

Health Canada is warning Canadians about another product seized from Dutta Health Centre-Ayurvedic Clinic.

December 23, 2019
·
5 min read
Deals

Monopar Therapeutics Inc. Announces Closing of Initial Public Offering of Common Stock

Monopar Therapeutics Inc. announced the closing of its initial public offering of 1,277,778 shares of common stock, including the underwriters’ exercise of its over-allotment option, at a public offering price of $8.00 per share before underwriting discounts and commissions.

December 23, 2019
·
1 min read
Business

EpiVax Announces Record Year for Growth in 2019 and Sets New Milestones for 2020

EpiVax continues its record-breaking performance and growth in personnel in 2019 while identifying new milestones to aspire to in 2020.

December 23, 2019
·
2 min read
Policy

Advisory - Health Canada warns Canadians about U-Dream herbal sleep-aid products after tests detect a substance similar to a prescription insomnia drug, which may pose serious health risks

Health Canada is advising Canadians that it has tested several U-Dream Lite and U-Dream Full Night herbal sleep-aid products and has found that they contain a substance similar to the prescription drug zopiclone, which may pose serious health risks.

December 23, 2019
·
3 min read
FDA

FDA approves new treatment for adults with migraine

The U.S. Food and Drug Administration approved Ubrelvy tablets for the acute treatment of migraine with or without aura in adults.

December 23, 2019
·
2 min read
FDA

Allergan Receives U.S. FDA Approval for UBRELVY™ for the Acute Treatment of Migraine with or without Aura in Adults

UBRELVY™ is the first and only oral CGRP receptor antagonist (gepant) FDA-approved for the acute treatment of migraine

December 23, 2019
·
9 min read
Policy

Teligent, Inc. Announces FDA Request for Further Data on Complex Drug

Teligent, Inc. announced its development partner has received a Complete Response Letter from the U.S. Food and Drug Administration for its abbreviated new drug application for its first complex drug indicated for an orphan disease population.

December 23, 2019
·
2 min read
BioCapital

Leidos, Intel, and First Genesis Earn ACT-IAC Blockchain Innovations Award

Leidos, Intel Corporation, and First Genesis announced their collaborative approach in developing blockchain technologies to improve healthcare has earned the American Council for Technology and Industry Advisory Council’s 2019 Audience Choice Award.

December 23, 2019
·
4 min read